Geovax Labs Inc (GOVX) Shares Soar Above 1-Year High

Geovax Labs Inc (NASDAQ: GOVX)’s stock price has increased by 10.25 compared to its previous closing price of 2.44. However, the company has seen a 21.72% increase in its stock price over the last five trading sessions. globenewswire.com reported 2024-12-09 that Adds to Growing Portfolio of Intellectual Property Assets ATLANTA, Ga., Dec. 09, 2024 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for Patent Application No.

Is It Worth Investing in Geovax Labs Inc (NASDAQ: GOVX) Right Now?

The stock has a 36-month beta value of 3.31. Opinions on the stock are mixed, with 3 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.”

The public float for GOVX is 9.39M, and at present, short sellers hold a 5.44% of that float. On December 31, 2024, the average trading volume of GOVX was 1.67M shares.

GOVX’s Market Performance

The stock of Geovax Labs Inc (GOVX) has seen a 21.72% increase in the past week, with a 1.89% rise in the past month, and a 22.27% gain in the past quarter. The volatility ratio for the week is 7.62%, and the volatility levels for the past 30 days are at 7.87% for GOVX. The simple moving average for the past 20 days is 13.57% for GOVX’s stock, with a 9.45% simple moving average for the past 200 days.

Analysts’ Opinion of GOVX

Many brokerage firms have already submitted their reports for GOVX stocks, with Alliance Global Partners repeating the rating for GOVX by listing it as a “Buy.” The predicted price for GOVX in the upcoming period, according to Alliance Global Partners is $15 based on the research report published on November 11, 2024 of the current year 2024.

ROTH MKM, on the other hand, stated in their research note that they expect to see GOVX reach a price target of $20. The rating they have provided for GOVX stocks is “Buy” according to the report published on July 16th, 2024.

Maxim Group gave a rating of “Buy” to GOVX, setting the target price at $8 in the report published on November 19th of the previous year.

GOVX Trading at 12.77% from the 50-Day Moving Average

After a stumble in the market that brought GOVX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.94% of loss for the given period.

Volatility was left at 7.87%, however, over the last 30 days, the volatility rate increased by 7.62%, as shares surge +5.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +25.47% upper at present.

During the last 5 trading sessions, GOVX rose by +20.36%, which changed the moving average for the period of 200-days by +43.01% in comparison to the 20-day moving average, which settled at $2.37. In addition, Geovax Labs Inc saw -50.32% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at GOVX starting from DODD DAVID A, who purchase 8,000 shares at the price of $1.95 back on Aug 09 ’24. After this action, DODD DAVID A now owns 26,661 shares of Geovax Labs Inc, valued at $15,600 using the latest closing price.

DODD DAVID A, the President, CEO of Geovax Labs Inc, purchase 8,209 shares at $2.27 during a trade that took place back on Feb 22 ’24, which means that DODD DAVID A is holding 18,661 shares at $18,663 based on the most recent closing price.

Stock Fundamentals for GOVX

Current profitability levels for the company are sitting at:

  • -7.67 for the present operating margin
  • -0.35 for the gross margin

The net margin for Geovax Labs Inc stands at -7.61. The total capital return value is set at -2.88. Equity return is now at value -276.02, with -178.10 for asset returns.

Currently, EBITDA for the company is -26.67 million with net debt to EBITDA at 0.35. When we switch over and look at the enterprise to sales, we see a ratio of 5.16. The receivables turnover for the company is 5.83for trailing twelve months and the total asset turnover is 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.17.

Conclusion

To sum up, Geovax Labs Inc (GOVX) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Most Popular

Related Posts